Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | MMP1 | P03956 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 2/20 | 0.39 |
| ▸ | MMP8 | P22894 | 2/20 | 0.39 |
| ▸ | MMP13 | P45452 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.38 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL195393 | 0.98 | GPR35 (0.44) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL27464031 | 0.98 | GPR35 (0.44) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL26980 | 0.98 | GPR35 (0.44) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL27922796 | 0.96 | GPR35 (0.43) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL10713774 | 0.96 | GPR35 (0.43) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL9389076 | 0.93 | GPR35 (0.41) | GPR35KMT2AMEN1TSHRCA1 | |
| Alcohol SCHEMBL3785734 | 0.90 | TSHR (0.39) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL28111354 | 0.89 | NSD2 (0.43) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL29083020 | 0.85 | GPR35 (0.43) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL9485087 | 0.85 | CTSB (0.41) | GPR35KMT2AMEN1TSHRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3293240-B1 | AGENT HAVING ANTI-ICE NUCLEATION ACTIVITY | THE SCHOOL CORPORATION KANSAI UNIV (JP) | 2020-04-08 | — | — | EP | disclosed |
| US-20180153194-A1 | AGENT HAVING ANTI-ICE NUCLEATION ACTIVITY | THE SCHOOL CORPORATION KANSAI UNIVERSITY (JP) | 2018-06-07 | — | — | US | disclosed |
| EP-3293240-A1 | AGENT HAVING ANTI-ICE NUCLEATION ACTIVITY | The School Corporation Kansai University (JP) | 2018-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180153194-A1 | AGENT HAVING ANTI-ICE NUCLEATION ACTIVITY | YBX1, YBX3, TPX2 | GPR35 4651/4885KMT2A 4449/4885MEN1 3157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.